Search Results - "Johnson BA"

Risk drinking and contraception effectiveness among college women.

Authors: Ingersoll KS Ceperich SD Nettleman MD et al.

Source: Psychology & Health. Nov2008, Vol. 23 Issue 8, p965-981. 17p.

Topiramate reduces the harm of excessive drinking: implications for public health and primary care.

Authors: Ma JZ Ait-Daoud N Johnson BA

Source: Addiction. Nov2006, Vol. 101 Issue 11, p1561-1568. 8p.

Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum ß-hexosaminidase as markers for alcohol consumption.

Authors: Javors MA Johnson BA

Source: Addiction. Dec2003 Supplement 2, Vol. 98, p45-50. 6p.

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

Authors: Johnson BA Ait-Daoud N Bowden CL et al.

Source: Lancet. 5/17/2003, Vol. 361 Issue 9370, p1677-1685. 9p.

Pills for speedballing or cocaine dependence.

Authors: Johnson BA (AUTHOR)

Source: Lancet. 5/27/2006, Vol. 367 Issue 9524, p1714-1716. 3p.

Rank-based estimation in the {ell}1-regularized partly linear model for censored outcomes with application to integrated analyses of clinical predictors and gene expression data.

Authors: Johnson BA Johnson, Brent A

Source: Biostatistics; Oct2009, Vol. 10 Issue 4, p659-666, 8p

Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.

Authors: Johnson BA Rosenthal N Capece JA et al.

Source: Archives of Internal Medicine. 6/9/2008, Vol. 168 Issue 11, p1188-1199. 12p.

Topiramate for treating alcohol dependence: a randomized controlled trial.

Authors: Johnson BA Rosenthal N Capece JA et al.

Source: JAMA: Journal of the American Medical Association. 10/10/2007, Vol. 298 Issue 14, p1641-1651. 11p.

Editorial. New weapon to curb smoking: no more excuses to delay treatment.

Authors: Johnson BA (AUTHOR)

Source: Archives of Internal Medicine. 8/14/2006, Vol. 166 Issue 15, p1547-1550. 4p.

Understanding and treating alcohol dependence.

Authors: Johnson BA Koob GF Schuckit MA et al.

Source: Alcoholism: Clinical & Experimental Research. Mar2006, Vol. 30 Issue 3, p567-584. 18p.

URL: 20005058

A randomized trial of inhaled cyclosporine in lung-transplant recipients.

Authors: Iacono AT Johnson BA Grgurich WF et al.

Source: New England Journal of Medicine. 1/12/2006, Vol. 354 Issue 2, p141-150. 10p.

Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.

Authors: Johnson BA Mann K Willenbring ML et al.

Source: Alcoholism: Clinical & Experimental Research. Aug2005, Vol. 29 Issue 8, p1528-1540. 13p.

Safety and efficacy of GABAergic medications for treating alcoholism.

Authors: Johnson BA Swift RM Addolorato G et al.

Source: Alcoholism: Clinical & Experimental Research. Feb2005, Vol. 29 Issue 2, p248-254. 7p.

A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (VIVITREX) in patients with alcohol dependence.

Authors: Johnson BA Ait-Daoud N Aubin H et al.

Source: Alcoholism: Clinical & Experimental Research. Sep2004, Vol. 28 Issue 9, p1356-1361. 6p.

Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study.

Authors: Johnson BA (AUTHOR)

Source: Alcoholism: Clinical & Experimental Research. Aug2004, Vol. 28 Issue 8, p1137-1144. 8p.

Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals.

Authors: Johnson BA Ait-Daoud N Ma JZ et al.

Source: Alcoholism: Clinical & Experimental Research. Nov2003, Vol. 27 Issue 11, p1773-1779. 7p.

Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.

Authors: Johnson BA Roache JD Javors MA et al.

Source: JAMA: Journal of the American Medical Association. 8/23/2000, Vol. 284 Issue 8, p963-971. 9p.

URL: 3457808

Copy number variation in pediatric multiple sclerosis.

Authors: McElroy, JP Krupp, LB Johnson, BA et al.

Source: Multiple Sclerosis Journal. Jul2013, Vol. 19 Issue 8, p1014-1021. 8p. 2 Color Photographs, 1 Diagram, 1 Chart, 2 Graphs.

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.

Authors: Aurora AB Mahmoud AI Luo X et al.

Source: Journal of Clinical Investigation. Apr2012, Vol. 122 Issue 4, p1222-1232. 11p.

Can serotonin transporter genotype predict craving in alcoholism?

Authors: Ait-Daoud N Roache JD Dawes MA et al.

Source: Alcoholism: Clinical & Experimental Research. Aug2009, Vol. 33 Issue 8, p1329-1335. 7p.

URL: 43303918